RCT of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion (AxA)
A Randomized Controlled Trial of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion
Sponsor: NuVasive
Listed as NCT01982045, this NA trial focuses on Instrumented Spinal Fusion and Spinal Deformity and remains completed. Sponsored by NuVasive, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
▶ Show 2 earlier versions
-
Nov 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Nov 2017 [monthly]
Active Not Recruiting NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NuVasive
- UMC Utrecht
For direct contact, visit the study record on ClinicalTrials.gov .